Manju L Prasad

Summary

Affiliation: University of Massachusetts Medical School
Country: USA

Publications

  1. ncbi Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma
    Manju L Prasad
    Department of Pathology, Ohio State University, Columbus, OH, USA
    Mod Pathol 21:105-14. 2008
  2. ncbi Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors
    Manju L Prasad
    Department of Pathology, The Ohio State University Medical Center, Columbus, OH 43210, USA
    Mod Pathol 18:48-57. 2005
  3. doi Vanishing thyroid tumors: a diagnostic dilemma after ultrasonography-guided fine-needle aspiration
    Ogechukwu P Eze
    Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520 8023, USA
    Thyroid 23:194-200. 2013
  4. doi BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance
    Adebowale J Adeniran
    Department of Pathology, Yale University School of Medicine, New Haven, Conn, USA
    Acta Cytol 55:570-5. 2011
  5. doi Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct
    Alexander Finkelstein
    Department of Pathology, Yale School of Medicine, 310 Cedar Street, New Haven, CT06520, USA
    Histopathology 60:1052-9. 2012
  6. pmc Prognostic significance of regulators of cell cycle and apoptosis, p16(INK4a), p53, and bcl-2 in primary mucosal melanomas of the head and neck
    Manju L Prasad
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Head Neck Pathol 6:184-90. 2012
  7. doi Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification
    Matthew J Horne
    Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA
    Diagn Cytopathol 40:410-5. 2012
  8. doi BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation
    Renu K Virk
    Department of Pathology, Yale School of Medicine, New Haven, CT, USA
    Mod Pathol 26:62-70. 2013
  9. ncbi Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck
    Manju L Prasad
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Head Neck 26:1053-7. 2004
  10. ncbi MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium
    Parish P Sedghizadeh
    Department of Oral and Maxillofacial Pathology, College of Dentistry, The Ohio State University, Columbus, OH, USA
    Med Sci Monit 11:BR189-94. 2005

Collaborators

Detail Information

Publications23

  1. ncbi Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma
    Manju L Prasad
    Department of Pathology, Ohio State University, Columbus, OH, USA
    Mod Pathol 21:105-14. 2008
    ....
  2. ncbi Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors
    Manju L Prasad
    Department of Pathology, The Ohio State University Medical Center, Columbus, OH 43210, USA
    Mod Pathol 18:48-57. 2005
    ..An immunohistochemical panel consisting of GAL3, FN1 and HBME1 may be useful in the diagnosis of follicular cell-derived thyroid tumors...
  3. doi Vanishing thyroid tumors: a diagnostic dilemma after ultrasonography-guided fine-needle aspiration
    Ogechukwu P Eze
    Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520 8023, USA
    Thyroid 23:194-200. 2013
    ..In this study, we highlight the diagnostic and management issues associated with the unintended consequences of ultrasonography (US)-guided FNA...
  4. doi BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance
    Adebowale J Adeniran
    Department of Pathology, Yale University School of Medicine, New Haven, Conn, USA
    Acta Cytol 55:570-5. 2011
    ..BRAF mutation occurs in 40-60% of papillary thyroid carcinoma (PTC). In this study, we examined cases in the AUS/FLUS category in correlation with BRAF mutation analysis and surgical pathology outcome...
  5. doi Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct
    Alexander Finkelstein
    Department of Pathology, Yale School of Medicine, 310 Cedar Street, New Haven, CT06520, USA
    Histopathology 60:1052-9. 2012
    ..This study was aimed at identifying distinctive features in tumours with and without the mutation...
  6. pmc Prognostic significance of regulators of cell cycle and apoptosis, p16(INK4a), p53, and bcl-2 in primary mucosal melanomas of the head and neck
    Manju L Prasad
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Head Neck Pathol 6:184-90. 2012
    ..Expression of bcl-2 is associated with better survival in MM. Loss of p16 was seen with tumor progression whereas aberrant p53 expression was frequent in undifferentiated tumor cells...
  7. doi Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification
    Matthew J Horne
    Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA
    Diagn Cytopathol 40:410-5. 2012
    ..Despite the vague morphologic criteria for this diagnostic category, the indeterminate rate remains relatively low and falls within the NCI recommendation (<7%)...
  8. doi BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation
    Renu K Virk
    Department of Pathology, Yale School of Medicine, New Haven, CT, USA
    Mod Pathol 26:62-70. 2013
    ..BRAF(V600E) mutation is an early event in thyroid carcinogenesis, and is associated with distinctive morphology and aggressive features even in papillary thyroid microcarcinomas...
  9. ncbi Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck
    Manju L Prasad
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Head Neck 26:1053-7. 2004
    ..Primary mucosal melanomas of the head and neck (HNMM) are rare aggressive malignant tumors that are usually difficult to treat. CTAs may provide useful targets for therapy; however, their expression in HNMM is not known...
  10. ncbi MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium
    Parish P Sedghizadeh
    Department of Oral and Maxillofacial Pathology, College of Dentistry, The Ohio State University, Columbus, OH, USA
    Med Sci Monit 11:BR189-94. 2005
    ..The purpose of this study was to evaluate MSG-1 protein expression in cutaneous and mucosal melanocytic lesions, with the aim to explore its association with pigment production, malignant potential and UV light exposure...
  11. doi Intracellular versican expression in mesenchymal spindle cell tumors contrasts with extracellular expression in epithelial and other tumors--a tissue microarray-based study
    Atul Bhardwaj
    Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA
    Appl Immunohistochem Mol Morphol 16:263-6. 2008
    ....
  12. doi Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study
    Adebowale J Adeniran
    Department of Pathology, Yale University, New Haven, Connecticut 06520, USA
    Thyroid 21:717-23. 2011
    ..Reflex BRAF testing may improve the diagnostic accuracy of thyroid fine-needle aspiration (FNA) tests having equivocal cytologic interpretations and provide prognostic information that helps guide management in patients with PTC...
  13. doi Comparative evaluation of high-throughput small-core (0.6-mm) and large-core (2-mm) thyroid tissue microarray: is larger better?
    Susie Jones
    Department of Pathology, Ohio State University Medical Center, Columbus, USA
    Arch Pathol Lab Med 136:199-203. 2012
    ..6-mm core of a large tumor would give results similar to results of the whole section. However, cores from colloid-filled thyroid follicles, for example in breast carcinoma, may contain fewer cells compared to solid tumors...
  14. doi Pleomorphic adenoma arising in an incidental midline isthmic thyroid nodule: a case report and review of the literature
    Gillian H Levy
    Department of Pathology, Yale University School of Medicine, New Haven, CT 06520, USA
    Hum Pathol 43:134-7. 2012
    ..We propose the possibility of origin in ectopic salivary gland tissue that may have aberrantly migrated with the median anlage from the foramen cecum in the base of the tongue during embryogenesis...
  15. ncbi Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, Stage I (lymph node-negative) tumors
    Manju L Prasad
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 100:1657-64. 2004
    ..The current study was conducted to identify histologic predictors of survival in patients with localized, lymph node-negative (Stage I, N0M0) primary mucosal melanomas of the head and neck (HNMM)...
  16. ncbi Allelic variation in gene expression in thyroid tissue
    Huiling He
    Human Cancer Genetics Program, The Ohio State University, Columbus, Ohio 43210, USA
    Thyroid 15:660-7. 2005
    ..DUOX1 variation in expression was seen in 3 of 13 patients with PTC and 6 of 27 patients with benign disease. Further studies are needed to determine the significance of these and other allelic variations...
  17. doi Lymphadenoma of the salivary gland: clinicopathological and immunohistochemical analysis of 33 tumors
    Raja R Seethala
    Department of Pathology, Presbyterian University Hospital, Pittsburgh, PA, USA
    Mod Pathol 25:26-35. 2012
    ..Altered immune status may have a role in their etiopathogenesis. Multiple synchronous tumors, origin in buccal mucosa, and malignant transformation may rarely occur...
  18. ncbi Variable expression of coxsackie-adenovirus receptor in thyroid tumors: implications for adenoviral gene therapy
    Derek K Marsee
    Medical Scientist Program, The Ohio State University, Columbus, Ohio, USA
    Thyroid 15:977-87. 2005
    ..Our study warrants a functional method to evaluate adenoviral infectivity should be developed and instituted prior to clinical trials of adenoviral gene therapy in patients with advanced thyroid cancer...
  19. ncbi CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study
    Manju L Prasad
    Department of Pathology, Ohio State University, Columbus, Ohio 43210, USA
    Thyroid 14:169-75. 2004
    ..CITED1 is preferentially expressed in PTC and may be used as a diagnostic marker of it...
  20. ncbi Primary mucosal desmoplastic melanoma of the head and neck
    Manju L Prasad
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Head Neck 26:373-7. 2004
    ..Desmoplastic variants of melanoma rarely affect the mucosa...
  21. ncbi Synovial sarcoma with rhabdoid features
    Ping Wen
    Department of Pathology, The Ohio State University Medical Center, Columbus 43210, USA
    Arch Pathol Lab Med 127:1391-2. 2003
  22. doi Laryngeal candidiasis mimicking malignancy
    Fabio P Nunes
    Department of Medicine, University of Massachusetts, Worcester, Massachusetts 01655, USA
    Laryngoscope 118:1957-9. 2008
    ..Biopsy of the lesion failed to show any signs of malignancy, and patient responded well to oral fluconazole therapy...
  23. ncbi Primary mucosal malignant melanoma of the head and neck
    Snehal G Patel
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Head Neck 24:247-57. 2002
    ..This study aims to assess the outcome and identify clinical and histologic prognostic indicators in a recent cohort of patients with MMHN treated at a single institution...